Adverse events36

Each adverse event the trial posted, group by group: the participants affected out of those at risk.

1 to 20 of 36

Type	Event	Organ system	Group	Affected	At risk	Events
serious	CMV infection	Infections and infestations	Sirolimus +Tacrolimus	5	86	5
serious	CMV infection	Infections and infestations	Everolimus +Tacrolimus	6	90	6
serious	CMV infection	Infections and infestations	Mycophenolate +Tacrolimus	24	90	25
serious	Dehiscence of the aponeurosis	Skin and subcutaneous tissue disorders	Sirolimus +Tacrolimus	1	86	1
serious	Dehiscence of the aponeurosis	Skin and subcutaneous tissue disorders	Everolimus +Tacrolimus	1	90	1
serious	Dehiscence of the aponeurosis	Skin and subcutaneous tissue disorders	Mycophenolate +Tacrolimus	2	90	2
serious	Acute graft dysfunction	Renal and urinary disorders	Sirolimus +Tacrolimus	1	86	1
serious	Acute graft dysfunction	Renal and urinary disorders	Everolimus +Tacrolimus	2	90	2
serious	Acute graft dysfunction	Renal and urinary disorders	Mycophenolate +Tacrolimus	0	90	0
serious	Renal artery stenosis	Vascular disorders	Sirolimus +Tacrolimus	1	86	1
serious	Renal artery stenosis	Vascular disorders	Everolimus +Tacrolimus	1	90	1
serious	Renal artery stenosis	Vascular disorders	Mycophenolate +Tacrolimus	1	90	1
serious	Acute gastroenterocolitis	Gastrointestinal disorders	Sirolimus +Tacrolimus	0	86	0
serious	Acute gastroenterocolitis	Gastrointestinal disorders	Everolimus +Tacrolimus	2	90	2
serious	Acute gastroenterocolitis	Gastrointestinal disorders	Mycophenolate +Tacrolimus	3	90	3
serious	Pyelonephritis	Renal and urinary disorders	Sirolimus +Tacrolimus	4	86	4
serious	Pyelonephritis	Renal and urinary disorders	Everolimus +Tacrolimus	6	90	6
serious	Pyelonephritis	Renal and urinary disorders	Mycophenolate +Tacrolimus	5	90	7
serious	Acute graft rejection	Renal and urinary disorders	Sirolimus +Tacrolimus	7	86	8
serious	Acute graft rejection	Renal and urinary disorders	Everolimus +Tacrolimus	6	90	6

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT03468478/events

API reference For AI assistants

Adverse events36

Sources 3

Read this list from software.